“Gypenosides improved inflammatory status, insulin resistance and hepatic steatosis in obese C57BL/6J mice : Gypenosides improved inflammatory status in obese mice”, JFB, vol. 21, Mar. 2023, doi: 10.31665/JFB.2023.18337.